Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

Chronic kidney disease affects 1 in 7 U.S. adults, underscoring the importance of early detection and management. This ...

Recently analyzed evidence points to a connection between oral health and kidney health, according to work led by University ...

A recent case study found a possible new trigger for a dangerous, and sometimes fatal, virus that could be laying dormant in ...

The cost of treating end-stage chronic kidney disease (CKD) in Malaysia has surged sharply from RM572 million in 2020 to ...

And it only takes a few minutes.

A national clinical trial is underway to test a device that could help patients with chronic kidney disease during the ...

Researchers from the Faculty of Medicine at Chulalongkorn University have identified a native probiotic strain, Lactobacillus ...

Access to kidney care will be expanded this year aimed at addressing the rising number of chronic kidney disease (CKD) cases ...

Black patients with chronic kidney diseases have faced historically longer waiting times for kidney transplants due to an ...